ES541394A0 - Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada - Google Patents

Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada

Info

Publication number
ES541394A0
ES541394A0 ES541394A ES541394A ES541394A0 ES 541394 A0 ES541394 A0 ES 541394A0 ES 541394 A ES541394 A ES 541394A ES 541394 A ES541394 A ES 541394A ES 541394 A0 ES541394 A0 ES 541394A0
Authority
ES
Spain
Prior art keywords
producing
long
dosage form
pharmaceutical dosage
term pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541394A
Other languages
English (en)
Other versions
ES8700935A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of ES541394A0 publication Critical patent/ES541394A0/es
Publication of ES8700935A1 publication Critical patent/ES8700935A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES541394A 1984-03-21 1985-03-20 Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada Expired ES8700935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59173884A 1984-03-21 1984-03-21

Publications (2)

Publication Number Publication Date
ES541394A0 true ES541394A0 (es) 1986-11-16
ES8700935A1 ES8700935A1 (es) 1986-11-16

Family

ID=24367713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541394A Expired ES8700935A1 (es) 1984-03-21 1985-03-20 Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada

Country Status (13)

Country Link
EP (1) EP0156592A3 (es)
JP (1) JPS61501511A (es)
KR (1) KR850700212A (es)
AU (1) AU4064285A (es)
DK (1) DK529885A (es)
ES (1) ES8700935A1 (es)
FI (1) FI854573A0 (es)
GB (1) GB2157169A (es)
GR (1) GR850625B (es)
HU (1) HUT38262A (es)
PT (1) PT80124B (es)
WO (1) WO1985004100A1 (es)
ZA (1) ZA851891B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
DE69739165D1 (de) 1996-07-08 2009-01-29 Penwest Pharmaceuticals Co Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
US8912192B2 (en) 2010-02-12 2014-12-16 Taisho Pharmaceutical Co., Ltd Extended release preparation
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
AU2014205356A1 (en) * 2013-01-09 2015-07-30 Edgemont Pharmaceuticals Llc Controlled release formulations of lorazepam

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.

Also Published As

Publication number Publication date
ZA851891B (en) 1986-10-29
DK529885D0 (da) 1985-11-15
EP0156592A3 (en) 1987-03-11
WO1985004100A1 (en) 1985-09-26
JPS61501511A (ja) 1986-07-24
FI854573A (fi) 1985-11-20
PT80124B (en) 1986-11-14
PT80124A (en) 1985-04-01
EP0156592A2 (en) 1985-10-02
KR850700212A (ko) 1985-12-26
DK529885A (da) 1985-11-15
GR850625B (es) 1985-06-17
FI854573A0 (fi) 1985-11-20
GB2157169A (en) 1985-10-23
HUT38262A (en) 1986-05-28
GB8506656D0 (en) 1985-04-17
AU4064285A (en) 1985-10-11
ES8700935A1 (es) 1986-11-16

Similar Documents

Publication Publication Date Title
ES541394A0 (es) Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada
ES538521A0 (es) Un procedimiento para producir una tableta de goma de mascar
ES557337A0 (es) Un procedimiento para producir una lamina estratificada
MX9203560A (es) Una forma de dosis para surtir pseudoefedrina.
ES541503A0 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
ES554507A0 (es) Un metodo para preparar una composicion de resina acrilica no gelificada
ES532317A0 (es) Una composicion farmaceutica
ES553977A0 (es) Un procedimiento para preparar una composicion oral
ES557321A0 (es) Procedimiento para producir un material fotomodulador
ES549033A0 (es) Una trampa para ratones
ES554101A0 (es) Un metodo para preparar una composicion dentifrica
MX9203559A (es) Una forma de dosificacion para administrar clorofeniramina.
ES542019A0 (es) Procedimiento para producir una n-acilfenilalanina
MX7384E (es) Un metodo para preparar una composicion germicida
ES540907A0 (es) Un metodo de producir una composicion farmaceutica estabili-zada
AR229182A1 (es) Unidad de construccion,y metodo para la produccion de una unidad de construccion
ES537162A0 (es) Una composicion farmaceutica
MX7581E (es) Procedimiento para preparar una composicion farmaceutica a base de famotidina
ES555170A0 (es) Un metodo para producir una composicion moldeada
ES557094A0 (es) Metodo para fabricar un producto encintado
AR230571A1 (es) Procedimiento para preparar una composicion farmaceutica
ES537186A0 (es) Un procedimiento para producir una benzoilurea
ES550537A0 (es) Un metodo para la produccion de una composicion moldeada
ES552218A0 (es) Un metodo para producir etanol
ES555853A0 (es) Un metodo para producir derivados de bromodicloroimidazol